Russell Maas

As the first GalaFLEX lawsuits continue to be filed in Rhode Island state court, regulators are still receiving reports of breast mesh complications that often result in removal of the breast implant. A growing number of women nationwide are reporting painful and debilitating GalaFLEX mesh complications, often resulting in the need for breast implant revision or removal surgery, after the surgical mesh product was used off-label during breast augmentation, breast lift or reconstruction surgery.

About 1 in 5 endoscopes remain contaminated even after following manufacturer cleaning instructions, with colonoscopy scopes showing the highest risk, as bacteria have been found in nearly 1 out of every 3 devices.

The hydrogel implant was designed to mimic natural cartilage and preserve motion in the big toe joint, but post market reports linked the device to pain, loosening and implant subsidence, prompting a series of Cartiva lawsuits. Mounting reports of surgical failures following Cartiva toe implant procedures are now fueling a rise in lawsuits nationwide, as research and patient outcomes have raised questions about the safety and effectiveness of the device.